Other news
Other news
Syndesi Therapeutics Awarded Non-dilutive Funding of up to €3.2M for Development of its Lead Program, SDI-118, Aimed at Treating Cognitive Impairment
Read full storyOther news
Calypso Biotech BV secures 20 Million EUR in Series A Financing to Develop Anti-IL-15 Therapeutic Antibody for Autoimmune Diseases
Read full storyOther news
Genome Biologics wins prestigious Horizon 2020 EU Phase 2 grant award
Read full storyOther news
Knowledge for Growth 2018 Recap
Read full storyOther news
Want to know more about the JLABS Portfolio?
Read full storyOther news